Chakaramakkil Mathew Jose, Sivathasan Cumaraswamy
Department of Cardiothoracic Surgery, National Heart Centre Singapore, 5 Hospital drive, Singapore, 169609 Singapore.
Indian J Thorac Cardiovasc Surg. 2021 Apr;37(Suppl 2):319-326. doi: 10.1007/s12055-020-00923-2. Epub 2020 Feb 11.
The aim of this review is to discuss the role of extracorporeal membrane oxygenation (ECMO) in cardiogenic shock and its use to bridge patients to heart transplantation.
Consideration of published literature reveals indications for ECMO in cardiogenic shock and tools for patient selection, adequate evidence of its efficacy, its advantages when compared with other temporary mechanical circulatory support devices and details of its use as a bridge to decision, bridge to recovery, bridge to bridge (durable ventricular assist device) and bridge to heart transplant.
ECMO is invaluable in treating patients with medically refractory profound cardiogenic shock and allows for cardiac recovery or planning for permanent heart replacement treatments.
本综述旨在探讨体外膜肺氧合(ECMO)在心源性休克中的作用及其作为患者心脏移植过渡手段的应用。
对已发表文献的考量揭示了ECMO在心源性休克中的适应证、患者选择工具、其疗效的充分证据、与其他临时机械循环支持装置相比的优势,以及其作为决策过渡、恢复过渡、桥接过渡(耐用心室辅助装置)和心脏移植过渡的使用细节。
ECMO在治疗药物难治性严重心源性休克患者方面具有重要价值,并有助于心脏恢复或规划永久性心脏替代治疗。